The Fortrea Podcast

Host: Dr. Mala Puri, Senior Medical Director at Fortrea  Participant: Dr. Sanjoy Dutta PhD, Chief Scientific Officer at Breakthrough T1D Description: This episode brings together Mala Puri, Senior Medical Director at Fortrea and Dr. Sanjoy Dutta PhD Chief Scientific Officer to discuss the unique challenges faced by pediatric populations in Type 1 diabetes clinical trials.   We explore the specific...

Obesity is a serious, chronic disease with multiple health consequences. Effective treatment should go beyond simply reducing body weight. It must focus on decreasing fat mass, improving body composition including preserving muscle mass and enhancing muscle quality addressing associated metabolic comorbidities, and ultimately improving overall quality of life. Today, scientific advances highlighte...

Host: Dr. Friedrich Mittermayer, Sr. Medical Director for Endocrinology, Fortrea Participant: Dr. Esther Latres PhD, VP of Research at Breakthrough T1D Description: This episode brings together Dr. Friedrich Mittermayer and Dr. Esther Latres PhD, VP of Research, to discuss the exciting cures for T1D, and the challenges those clinical trials face. This podcast episode explores the urgent realities...

In this episode, we hear from Sarah, a patient living with obesity and a passionate advocate, as she shares her personal experience participating in clinical trials. Sarah reflects on the emotional and practical motivations that drive patients to join studies—from the hope of accessing new treatments to the desire to contribute to scientific progress. She emphasizes the importance of transparency,...

In this episode, we hear from Sarah, a patient living with obesity, as she shares her lifelong journey—from early body image struggles and restrictive dieting to participating in a televised weight-loss transformation. Despite achieving peak fitness and completing an Olympic triathlon, Sarah’s weight returned, prompting her to explore the science behind obesity. Her discovery of metabolic adaptati...

Host: Amber Burg, Therapeutic Delivery Head of Neuroscience and Ophthalmology at Fortrea  Participants:  Abby Fuller, Senior Director of Strategic Delivery Growth in Neuroscience, Fortrea  Walter Gonzalez, Associate Director, Digital Health and Innovation, Fortrea  Haiyan Wei, SVP of Technology and Operations at AI Cure   Description: From digital endpoint real-world examples to strategic insights...

Host: Amber Burg, Therapeutic Delivery Head of Neuroscience and Ophthalmology at Fortrea Participants:   Leone Atkinson, Executive Medical Director of Neuroscience and Ophthalmology at Fortrea Alicia Baker, Vice President, Head of Global Regulatory Strategy at Fortrea Description: Digital endpoints are no longer a future ambition—they’re shaping neuroscience trials today. In this episode, we explo...

Host: Dr. Cheerag Shirodaria, VP and Cardiovascular/Metabolic Therapeutic Area Head, Fortrea Participant: Chris Farina, Abcentra CEO  Description: In episode two, the conversation turns to clinical development and the power of imaging biomarkers. Dr. Cheerag Shirodaria (Fortrea) and Chris Farina (Abcentra) delve into how innovations in technology and imaging, such as coronary CT angiography (CCTA)...

Host: Dr. Cheerag Shirodaria, VP and Cardiovascular/Metabolic Therapeutic Area Head, Fortrea Participant: Chris Farina, Abcentra CEO  Description: Despite advances in lipid-lowering and antithrombotic therapies, residual cardiovascular risk remains a major challenge. In this episode, Dr. Cheerag Shirodaria, Fortrea's cardiovascular lead, and Chris Farina, CEO of Abcentra, explore the emerging...

Host: Amber Burg, Therapeutic Delivery Head of Neuroscience and Ophthalmology at Fortrea Participants:   Leone Atkinson, Executive Medical Director of Neuroscience and Ophthalmology, Fortrea Robin Wolz, Chief Scientific Officer at Ixico  Description: This episode features an insightful interview between Fortrea neuroscience leaders and experts from Ixico, focusing on novel imaging biomarkers in Pa...

Host: Amber Burg, Therapeutic Delivery Head of Neuroscience and Ophthalmology at Fortrea Participants:   Joanie Brown, Head of Operations at our Rapid Development Studio AI/ML, Fortrea Mark Austin, CTO at Ixico  Description: In this episode of the Fortrea neuroscience podcast, we explore how AI is transforming Parkinson’s research—from bold promises to practical breakthroughs.  Fortrea’s Amber Bur...

In this episode, “How to Maximize Valuation for Minimal Cost,” we explore a critical question: Are you focused on regulatory approval, or on maximizing value? Your answer could determine the path your clinical trial takes, and the outcome it delivers. Our moderator, Dr. Ken Park, is joined by an exceptional group of speakers: Tracy Newbold, VP of Clinical Operations at Lexicon Pharmaceuticals; Ter...

This episode explores innovative approaches to enhance productivity within clinical trials, focusing on the use of technology and data-driven strategies. Our moderator, Dr. Ken Park, is joined by an exceptional group of speakers: Tracy Newbold, VP of Clinical Operations at Lexicon Pharmaceuticals; Terry Athreya, SVP and Global Head of Clinical Operations for Fortrea; and Alaric Jackson, Chief Tech...

In our third episode, we discuss collaboration between Contract Research Organizations and biotech companies, emphasizing the importance of communication and understanding in clinical trials. Our moderator, Dr. Ken Park, is joined by an exceptional group of speakers: Tracy Newbold, VP of Clinical Operations at Lexicon Pharmaceuticals; Terry Athreya, SVP and Global Head of Clinical Operations for F...

This episode is part of the 'Project Optimus' series exploring oncology trial reform. Overview: Behind every optimized dose is a robust framework of modeling, simulation, and thoughtful study design. Host Abigail Beanie returns to guide listeners through the technical backbone of Project Optimus. This episode explores how data-driven tools are transforming oncology trials and enabling mo...

This episode is part of the 'Project Optimus' series exploring oncology trial reform. Overview: Description: How do you bring Project Optimus from concept to clinic? In this episode, Dr. Shanthi Sundaramoorthy, Senior Director of Fortrea’s Strategic Growth and Delivery Team in Oncology, shares actionable insights on how sponsors can adapt early-phase trial designs to align with the FDA’s...

This episode is part of the 'Project Optimus' series exploring oncology trial reform. Overview: What is Project Optimus, and why is it reshaping the future of oncology drug development? In this kickoff episode, we unpack the FDA’s initiative to modernize dose optimization in cancer trials. Join host Abigail Beanie as she speaks with Audrey Finesso, Senior Director of Clinical Regulatory...

Dive into our first episode of the "Sustainability in Clinical Trials" series!  🎧 In this 2-part episode, we explore innovative strategies to drive sustainability and profitability in tandem. Join host John Kennett and our expert panelists Carly Santer, Andrea Robinson-Smith, Ida Corneliusson, Keith Moore, Claire Campbell-Cooper, and Marlene Knupfer as they discuss the current state of...

Tune in to the second episode of our "Sustainability in Clinical Trials" series!  🎧 This 2-part episode delves into how sustainability strategies drive speed and efficiency in drug development. Host John Kennett is joined by Carly Santer, Andrea Robinson-Smith, Ida Corneliusson, Keith Moore, Claire Campbell-Cooper, and Marlene Knupfer to discuss the obstacles slowing progress and share...

Don't miss the third episode of our "Sustainability in Clinical Trials" series!  🎧 In this 2-part episode, host John Kennett and panelists Caleb Tuten, Lisa Moneymaker, Fiona Adshead, and Marlene Knupfer discuss the vital role of partnerships in driving adoption of sustainable thinking in clinical trial design. They emphasize how organizations across sectors can come together to sh...

Join us for the fourth episode of our "Sustainability in Clinical Trials" series!  🎧 This 2-part episode delves into the crucial role of partnerships in challenging established thinking of sustainability and clinical trial design. Host John Kennett is joined by Caleb Tuten, Lisa Moneymaker, Fiona Adshead, and Marlene Knupfer to discuss how organizations can collaborate to share resource...

Overview: In this 2-part episode, we look a little beyond clinical trials, taking a complex systems view on how sustainability thinking is shaping the future of healthcare as a whole, and the role that our industry must play in informing and promoting this way of thinking.  Participants:   ·         Host: John Kennett, Director, Global Marketing at Fortrea ·         Jason Laroche, Director of Inno...

Overview: In this 2-part episode, we look a little beyond clinical trials, taking a complex systems view on how sustainability thinking is shaping the future of healthcare as a whole, and the role that our industry must play in informing and promoting this way of thinking.  Participants:   ·         Host: John Kennett, Director, Global Marketing at Fortrea ·         Jason Laroche, Director of Inno...